Update on 340B and Healthcare Reform

Tuesday, December 29, 2009

Currently, the Senate version of the Health Care Reform bill includes provisions to allow the use of 340B drugs in the Inpatient setting of Disproportionate Share Hospitals.

In order to take advantage of this new opportunity, hospitals will be required to provide specific new reporting to Medicaid for the drugs (including 11 digit NDC and actual acquisition cost information) administered to their respective patients.

This type of detailed reporting of the inpatient environment is well beyond the current scope of 340B and traditional “split-billing” software, and underscores the importance of having a healthcare intelligence application that provides an auditable record.

Sentry Data Systems follows healthcare legislation closely. We’ve made sure that Sentinel RCM is currently configured to provide you the essential reporting and compliance requirements necessary to meet the demands of this new legislation so you can continue benefitting from 340B without missing a beat.

Our Philosophies

Simplify the Complicated

Our products are built to provide you information as you need it, when you need it, and supply the underlying detail as you want it. 340B is a very detailed, complicated regulation that involves many different areas of the healthcare delivery environment. Our products take this challenge, simplify it and fit into your existing processes while simplifying your workflow across the board.

Not-for-Profit Hospitals Increase Savings with “Own Use” Pricing

Not-for-profit hospitals are permitted to use GPO priced medications for their own employees and patients, and over 10 other eligible categories, but the operational challenges often mean this cost saving benefit goes unrealized. Our solutions automate the incorporation of Own Use pricing and provide all the necessary compliance tracking for both programs.

Address All Aspects of Compliance

340B Compliance is complicated and while the financial impact is significant, so is the administrative burden. To maintain compliance, a few required features are; documented, enforced policies and procedures, match purchases to drug dispensations, match dispensations to eligible patients and providers, and a documented electronic record of all activity. No other system available today incorporates all of these requirements in one seamless package.

Enjoy a Total Solution

Sentry is the only organization to offer comprehensive 340B services that include the mixed-use hospital setting (Sentinel RCM™), bring hospitals into retroactive compliance (Sentinel Reclaim™), and address the contract pharmacy retail setting (Sentrex™).

Together these services offer an incomparable total solution that provides unparalleled financial ROI, integrated and seamless use, unmatched regulatory compliance, and a drastic reduction of workload.

Swift & Painless Installation

To ease implementations, Sentry provides:

• Full expert installation assistance to integrate your Hospital Information Systems.
• Code for data extracts that are custom to Sentry, with installation provided by Sentry’s experts.
• A full project team that includes a project manager, an HIS Expert, and two technical analysts who are focused on getting you up and running.
• A 90 day target for installs, with the bulk of effort being performed by Sentry.

Maximize Your Financial Gain

Because our solutions are so flexible and comprehensive, we’re able to significantly enhance the financial performance of the 340B program at your facility. Not only will you see your 340B financial benefits maximized, but you’ll also realize significant non-340B financial benefits from our comprehensive formulary controls and a highly visible environment. In addition to 340B savings, Sentry Customers enjoy significant hard dollar savings by leveraging the full suite of Sentry’s technology solutions.